MedPath

POLIVY

POLIVY

Approved
DIN Number

02499614

Drug Class

Human

Market Date

Nov 25, 2020

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02499614
AIG Number0162275001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FX14 POLATUZUMAB VEDOTIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

POLATUZUMAB VEDOTINActive
Strength: 140 MG / VIAL
Monograph: POLATUZUMAB VEDOTIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.